We are live on ! Find out more
LJPC

La Jolla Pharmaceutical

Delisted

LJPC was delisted on the 19th of August, 2022.

83 hedge funds and large institutions have $718M invested in La Jolla Pharmaceutical in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 15 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 15

122% more call options, than puts

Call options by funds: $11.7M | Put options by funds: $5.28M

72% more capital inflows, than outflows

Capital inflows: $118M | Capital outflows: $68.6M

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

7.14% more ownership

Funds ownership: 101.87% → 109% (+7.1%)

14% less funds holding

Funds holding: 96 → 83 (-13)

44% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 25

Holders
83
Holders Change
-13
Holders Change %
-13.54%
% of All Funds
2.06%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
14
Increased
46
Reduced
15
Closed
25
Calls
$11.7​M
Puts
$5.28​M
Net Calls
+$6.45​M
Net Calls Change
+$6.42​M

LJPC Hedge Fund Activity: Q2 2017 in Review

83 of the 4,025 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical (LJPC) for Q2 2017, worth a combined $718M — up 6.9% from $672M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of LJPC and 14 opened new positions — a net loss of 11 holders — while 15 trimmed existing stakes and 46 added.

The largest buyer was State Street, adding an estimated $23.7M. The largest seller was Franklin Resources, exiting entirely with an estimated $24.3M sold.

  • 83 institutional investors held La Jolla Pharmaceutical (LJPC) as of Q2 2017, down from 96 in Q1 2017.
  • Funds reported $718M of La Jolla Pharmaceutical stock for Q2 2017, up 6.9% quarter-over-quarter.
  • 14 funds opened new La Jolla Pharmaceutical positions in Q2 2017 and 25 closed out, a net change of -11 holders.
  • The largest La Jolla Pharmaceutical buyer in Q2 2017 was State Street, an estimated $23.7M added.
  • The largest La Jolla Pharmaceutical seller in Q2 2017 was Franklin Resources, an estimated $24.3M sold.

Based on aggregated 13F filings for Q2 2017.